Stock Events

Stock Events

Greenbrook TMS 

C$0.97
5
+C$0+0% Tuesday 02:59

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

27MarExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Q4 2023
-0.59
-0.39
-0.2
0
Expected EPS
-0.15
Actual EPS
0

Financials

-46.05%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
25.14MRevenue
-11.58MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GTMS.TO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap106.97B
Medtronic offers neuromodulation devices including those for brain stimulation, directly competing in the mental health treatment market.
Nutriband
NTRB
Mkt Cap47.36M
NeuroOne Medical Technologies develops technology for neurological disorders, competing in the broader neurostimulation and mental health market.
Roundhill Magnificent Seven
MAGS
Mkt Cap0
Magstim provides Transcranial Magnetic Stimulation equipment, directly competing in the TMS technology sector that Greenbrook operates in.
Brainsway
BWAY
Mkt Cap655.34M
Brainway Deep TMS is a provider of deep transcranial magnetic stimulation, competing in the same technology space as Greenbrook TMS.
Abbvie
ABBV
Mkt Cap351.47B
AbbVie, through its acquisition of Allergan, has treatments for psychiatric conditions, indirectly competing with Greenbrook's TMS services.
Lilly(Eli) &
LLY
Mkt Cap789.69B
Eli Lilly produces psychiatric medications, offering alternative treatments to TMS for conditions like depression.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.68B
Teva Pharmaceutical Industries manufactures generic drugs including CNS treatments, providing alternative solutions to TMS.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson, through its Janssen Pharmaceuticals division, offers medications for mental health, competing with TMS treatments indirectly.

About

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. William P. Leonard
Employees
394
Country
Canada
ISIN
CA3937041018

Listings

0 Comments

Share your thoughts

FAQ

What is Greenbrook TMS stock price today?▼
The current price of GTMS.TO is C$0.97 CAD — it has increased by +0% in the past 24 hours. Watch Greenbrook TMS stock price performance more closely on the chart.
What is Greenbrook TMS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Greenbrook TMS stocks are traded under the ticker GTMS.TO.
What were Greenbrook TMS earnings last quarter?▼
GTMS.TO earnings for the last quarter are -0.59 CAD per share, whereas the estimation was -0.22 CAD resulting in a -168.18% surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is Greenbrook TMS revenue for the last year?▼
Greenbrook TMS revenue for the last year amounts to 25.14M CAD.
What is Greenbrook TMS net income for the last year?▼
GTMS.TO net income for the last year is -11.58M CAD.
How many employees does Greenbrook TMS have?▼
As of April 29, 2026, the company has 394 employees.
In which sector is Greenbrook TMS located?▼
Greenbrook TMS operates in the Health & Wellness sector.
When did Greenbrook TMS complete a stock split?▼
Greenbrook TMS has not had any recent stock splits.
Where is Greenbrook TMS headquartered?▼
Greenbrook TMS is headquartered in Toronto, Canada.